1. University of Pennsylvania, Philadelphia, PA, USA
2. Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA
3. GSK, Rue de l’Institut 89, Rixensart, Belgium
4. Hospital Quirón Madrid, Pozuelo de Alarcón, Spain
5. University of California Medical Center, San Francisco, CA, USA
6. Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
7. Haematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, UK
8. Vancouver General Hospital, Vancouver, BC, Canada
9. U.O. di Ematologia, Ospedale Santa Maria Delle Croci, Ravenna, Italy
10. Unità Operativa di Ematologia, Azienda Osp. Universitaria Arcispedale S. Anna, Cona, Italy
11. GSK, Rockville, MD, USA
12. National Cancer Center, Goyang-si, Republic of Korea
13. Hospital Universitario Central de Asturias, Oviedo, Spain
14. Department of Clinical Haematology, Austin Health, Heidelberg, Australia
15. Universitaetsklinikum Schleswig-Holstein, Kiel, Germany
16. Halozyme Therapeutics, San Diego, CA, USA
17. Hematology Department & CIBERONC, Instituto Carlos III, Hospital Universitario y Politécnico la fe, Valencia, Spain
18. Chonbuk National University Hospital, DukJin-Gu, Republic of Korea
19. Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
20. CureVac AG, Tübingen, Germany
21. Hospital Clínico San Carlos, Madrid, Spain
22. Division of Hematology and Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
23. Hematology Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
24. Ege University Medical Faculty Hospital, Izmir, Turkey
25. Hematology Department, Hospital Universitario Marqués De Valdecilla-IDIVAL, University of Cantabria, Santander, Spain
26. Hematologie - Oncologie, Ziekenhuisnetwerk Antwerpen - ZNA Stuivenberg & ZNA Middelheim, Antwerpen, Belgium
27. GSK, Wavre, Belgium